Skip to main content
Journal cover image
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition

Disorders of Pyridoxine Metabolism

Publication ,  Chapter
Van Karnebeek, C; Gospe, SM
November 13, 2014

Disorders of pyridoxine metabolism include pyridoxine-dependent epilepsy (PDE), pyridoxal-5′-phosphate- responsive epileptic encephalopathy, and tissue nonspecific isoenzyme of alkaline phosphatase deficiency. This chapter focuses on antiquitin (ATQ) deficiency, which is the main cause of autosomal recessive PDE and is characterized by early-onset epileptic encephalopathy resistant to antiepileptic medications but responsive to pharmacologic dosages of pyridoxine, which is a life-long requirement.ATQ, an aldehyde dehydrogenase in the lysine degradation pathway, is encoded by the ALDH7A1 gene. ATQ deficiency results in accumulation of α-aminoadipic semialdehyde (αAASA), piperideine-6-carboxylate, and pipecolic acid, which serve as diagnostic markers in urine, plasma, and cerebrospinal fluid (CSF). Elevated αAASA and at least one mutation in the ALDH7A1 gene are required for diagnostic confirmation.Ongoing research focuses on the effects of dietary lysine restriction in the management of ATQ deficiency, the delineation of the clinical spectrum of the disease (including neuroimaging findings), correlations between genotype and clinical and biochemical phenotypes, and molecular biology, as well as better understanding of the pathophysiology of this metabolic epilepsy. An international PDE Consortium has been established, employing collaborative data-sharing, digital media and novel trial methodologies, to attain these goals.

Duke Scholars

DOI

ISBN

9780124105492

Publication Date

November 13, 2014

Start / End Page

541 / 555
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Van Karnebeek, C., & Gospe, S. M. (2014). Disorders of Pyridoxine Metabolism. In Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition (pp. 541–555). https://doi.org/10.1016/B978-0-12-410529-4.00049-8
Van Karnebeek, C., and S. M. Gospe. “Disorders of Pyridoxine Metabolism.” In Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition, 541–55, 2014. https://doi.org/10.1016/B978-0-12-410529-4.00049-8.
Van Karnebeek C, Gospe SM. Disorders of Pyridoxine Metabolism. In: Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 2014. p. 541–55.
Van Karnebeek, C., and S. M. Gospe. “Disorders of Pyridoxine Metabolism.” Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition, 2014, pp. 541–55. Scopus, doi:10.1016/B978-0-12-410529-4.00049-8.
Van Karnebeek C, Gospe SM. Disorders of Pyridoxine Metabolism. Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 2014. p. 541–555.
Journal cover image

DOI

ISBN

9780124105492

Publication Date

November 13, 2014

Start / End Page

541 / 555